Profarma Distribuidora Profit Margin vs. Net Income

PFRM3 Stock  BRL 7.04  0.32  4.76%   
Based on the key profitability measurements obtained from Profarma Distribuidora's financial statements, Profarma Distribuidora de may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Profarma Distribuidora's ability to earn profits and add value for shareholders.
For Profarma Distribuidora profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Profarma Distribuidora to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Profarma Distribuidora de utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Profarma Distribuidora's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Profarma Distribuidora de over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Please note, there is a significant difference between Profarma Distribuidora's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profarma Distribuidora is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profarma Distribuidora's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Profarma Distribuidora Net Income vs. Profit Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Profarma Distribuidora's current stock value. Our valuation model uses many indicators to compare Profarma Distribuidora value to that of its competitors to determine the firm's financial worth.
Profarma Distribuidora de is considered to be number one stock in profit margin category among its peers. It also is considered to be number one stock in net income category among its peers making up about  6,683,076,923  of Net Income per Profit Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Profarma Distribuidora's earnings, one of the primary drivers of an investment's value.

Profarma Net Income vs. Profit Margin

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profarma Distribuidora

Profit Margin

 = 

Net Income

Revenue

X

100

 = 
0.01 %
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Profarma Distribuidora

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
78.19 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Profarma Net Income Comparison

Profarma Distribuidora is currently under evaluation in net income category among its peers.

Profarma Distribuidora Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Profarma Distribuidora, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Profarma Distribuidora will eventually generate negative long term returns. The profitability progress is the general direction of Profarma Distribuidora's change in net profit over the period of time. It can combine multiple indicators of Profarma Distribuidora, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Profarma Distrib Prod Farmaceuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil. PROFARMA operates under Medical Distribution classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 6327 people.

Profarma Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Profarma Distribuidora. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Profarma Distribuidora position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Profarma Distribuidora's important profitability drivers and their relationship over time.

Use Profarma Distribuidora in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Profarma Distribuidora position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profarma Distribuidora will appreciate offsetting losses from the drop in the long position's value.

Profarma Distribuidora Pair Trading

Profarma Distribuidora de Pair Trading Analysis

The ability to find closely correlated positions to Profarma Distribuidora could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Profarma Distribuidora when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Profarma Distribuidora - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Profarma Distribuidora de to buy it.
The correlation of Profarma Distribuidora is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Profarma Distribuidora moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Profarma Distribuidora moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Profarma Distribuidora can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Profarma Distribuidora position

In addition to having Profarma Distribuidora in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Global Macro ETFs Thematic Idea Now

Global Macro ETFs
Global Macro ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Profarma Stock Analysis

When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.